An Open Label, Randomised, Single-centre, Two Sequence, Cross-over Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 microg, 400 microg and 2 x 400 microg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects Using a Population PK Approach

Trial Profile

An Open Label, Randomised, Single-centre, Two Sequence, Cross-over Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 microg, 400 microg and 2 x 400 microg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects Using a Population PK Approach

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2013

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Oct 2012 Actual end date changed from Feb 2012 to Dec 2011 as reported by ClinicalTrials.gov.
    • 04 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 10 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top